Status:

UNKNOWN

Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection

Lead Sponsor:

Kasr El Aini Hospital

Conditions:

Infertility

Eligibility:

FEMALE

18-40 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to determine the effect of giving cabergoline to patients at risk of OHSS (ovarian hyperstimulation syndrome) after ovum pick up, on endometrial vascularity and it's effec...

Detailed Description

Following ethical approval of the committee of obstetrics \& gynecology IVF department of kasr al-Aini hospital Cairo University, 150 women attending the IVF unit of Kasr el Aini hospital for manageme...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age ≥18 - ≤40 years
  • Normal serum prolactin level.
  • Tubal factor of infertility.
  • Unexplained infertility.
  • BMI ≥ 30 kg/m2.
  • Estradiol (E2)\>3,500 pg/ml on day of ovulation trigger.
  • Patients who underwent coasting for OHSS prevention.
  • More than 20 follicles ≥11 mm on the day of final oocyte maturation.
  • Exclusion criteria:
  • Contraindication of pregnancy e.g.: Somatic and mental diseases, which are contraindications for carrying of a pregnancy and childbirth, inborn malformations or acquired deformations of uterus cavity which make embryo implantation or carrying of a pregnancy impossible ,ovarian tumors.
  • Severe Male factor infertility.
  • Hyperprolactinemic patients.
  • Frozen embryo transfer cycles
  • Uterine Anomalies.
  • Uterine synechia.
  • History of Genital Tuberculosis.
  • Repeated implantation failure in ICSI.
  • On medication that is known to alter prolactin levels e.g antipsychotics, Atypical agents and risperidone
  • Thyroid dysfunction.
  • Medical disorders affecting serum prolactin eg acromegaly ,chronic renal failure and hypothyroidism

Exclusion

    Key Trial Info

    Start Date :

    December 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2017

    Estimated Enrollment :

    150 Patients enrolled

    Trial Details

    Trial ID

    NCT02306564

    Start Date

    December 1 2014

    End Date

    December 1 2017

    Last Update

    December 6 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Assissted reproduction unit Kasr alaini hospital

    Ḩadā’iq al Qubbah, Cairo Governorate, Egypt, 11562